E2112 – A Randomized Phase III Trial of Endocrine Therapy plus Entinostat or Placebo in Patients with Hormone Receptor-Positive Advanced Breast Cancer

News Articles:

Newsletters for Participating Sites:

Physician and Research Staff Educational Materials:

These materials are intended for promotional use among health care professionals and are NOT intended for use as patient educational materials.

  • Physician Fact Sheet: schema, study objectives, eligibility criteria, and other key information about the study.
  • Pocket Reference Card: trial schema, study objectives, and eligibility requirements on a pocket-sized card for easy reference when consulting with patients in the office or on rounds.
  • Study Summary for Physicians: schema, study objectives, eligibility criteria, and other key information about the study.
  • Trial Overview Slide Deck (to come)

Patient Educational Materials:

Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material. For sites utilizing local IRBs, please submit this in accordance with your local IRB policies prior to use.

Additional Information on Cancer.gov: Displayed below is an interactive view of the study record as it appears in the government registry. If you are experiencing technical difficulties with this view, visit clinicaltrials.gov and search for record NCT02115282.